Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-18-050188

Options or other derivatives

  • President, R & D acquired 678,720 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Amado Rafael President, R & D 2018-08-06 Grant or award · Option to purchase Ordinary Shares +678,720 678,720 D
Loading xslF345X03/a4.xml…